Science often needs more than experiments.
Our discovery of Novltex, a new antibiotic class, is built on serendipity, persistence – and perhaps the wishes of millions already impacted by antimicrobial resistance. #teixobactin#clovibactin
👉DOI: https://t.co/00JNVa9Eq0
#AMR
This platform builds on Liverpool’s work on teixobactins, inspired by Novo29/clovibactin.
🙏Thanks to our collaborators, reviewers & funders.
⚠️Still early stage: further testing in animals & humans is needed before Novltex can reach patients.
#DrugDiscovery#GlobalHealth
🎉 Delighted to share that @livuniversity has won the Health Category of the @RoySocChem#EmergingTechComp for our synthetic teixobactins platform!
🦠💊 New class of antibiotics
👏 Kudos to Anish Parmar for presenting flawlessly—even during a power cut!
🔗 https://t.co/9EU7FkWWix
🎉 Congratulations to Teresa Tsz Ying To on successfully passing her PhD viva! Your hard work, dedication, and passion for research have truly paid off. I’m so proud of all you’ve accomplished.
A special thank you to examiners Dr. Gemma Nixon and Professor Mire Zloh .
Announcing our 24 finalists for the 2025 Emerging Technologies Competition, selected by our esteemed panel of judges. Take a look at the proposals from this year’s leading chemistry tech innovators vying for a share of the £100,000 cash prize. https://t.co/hJbx5Iejl4
🌟 Honoured to be a Finalist! 🌟
Thrilled to share that our work has been selected as a finalist in the Health category of the 2025 Emerging Technologies Competition, organised by the Royal Society of Chemistry! 🧪✨ @pandtuol@LivUniISMIB#teixobactin
https://t.co/enMlRHdACh
This recognition reaffirms the potential of our approach to deliver meaningful healthcare impact. Looking forward to pitching at the finals in July and connecting with fellow innovators transforming science into solutions.
It's a privilege to be recognised by a distinguished panel of judges with deep expertise in translating innovative chemistry into impactful health solutions. Our research focuses on tackling antimicrobial resistance through next-generation antibiotics—a pressing global challenge.
🚀 Fantastic fully-funded PhD opportunity!
Join the Bioenergetics Group at @LivUni@pandtuol to explore mitochondrial DNA’s role in Linezolid toxicity for drug-resistant TB. Work with experts and develop interdisciplinary skills.
🔗 Learn more: https://t.co/kuSYcTXmua